Role of Preoperative Cardiovascular Magnetic Resonance in Planning Ventricular Septal Myectomy in Patients With Obstructive Hypertrophic Cardiomyopathy.


Journal

The American journal of cardiology
ISSN: 1879-1913
Titre abrégé: Am J Cardiol
Pays: United States
ID NLM: 0207277

Informations de publication

Date de publication:
01 05 2019
Historique:
received: 15 11 2018
revised: 20 01 2019
accepted: 22 01 2019
pubmed: 23 2 2019
medline: 21 1 2020
entrez: 23 2 2019
Statut: ppublish

Résumé

In obstructive hypertrophic cardiomyopathy (HC), extreme heterogeneity of septal morphology makes septal myectomy particularly challenging. Although cardiovascular magnetic resonance (CMR) reconstructs ventricular anatomy with high spatial resolution, CMR is not used systematically to plan preoperatively septal myectomy. In this study, we report our results with using CMR to plan the extent of septal excision in 112 consecutive HC patients who subsequently underwent myectomy. Depth and length of the myectomy planned at CMR were compared with those of the septal muscle excised in a single piece in all patients. Anterior septum maximal thickness at CMR was 22 ± 5 mm and excised muscle thickness 9 ± 3 mm. Planned myectomy length was 35 ± 11 mm (range 17 to 65) and excised muscle length 38 ± 10 mm (range 10 to 70), indicating extension of septal resection to mid-cavity. Thickness and length of the planned myectomy showed a significant correlation with the excised muscle (R

Identifiants

pubmed: 30791998
pii: S0002-9149(19)30170-5
doi: 10.1016/j.amjcard.2019.01.041
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1517-1526

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Paolo Spirito (P)

Policlinico di Monza, Monza, Italy. Electronic address: paolo.spirito@policlinicodimonza.it.

Irene Binaco (I)

Policlinico di Monza, Monza, Italy.

Daniele Poggio (D)

Policlinico di Monza, Monza, Italy.

Aleksei Zyrianov (A)

Policlinico di Monza, Monza, Italy.

Massimiliano Grillo (M)

Policlinico di Monza, Monza, Italy.

Laura Pezzoli (L)

Laboratorio di Genetica Medica, Ospedale Papa Giovanni XXIII, Bergamo, Italy.

Jessica Rossi (J)

Policlinico di Monza, Monza, Italy.

Dmitri Malanin (D)

Policlinico di Monza, Monza, Italy.

Giuseppe Vaccari (G)

Policlinico di Monza, Monza, Italy.

Lucian Dorobantu (L)

Policlinico di Monza, Monza, Italy; Spitalul Monza, Bucharest, Romania.

Maria Iascone (M)

Laboratorio di Genetica Medica, Ospedale Papa Giovanni XXIII, Bergamo, Italy.

Andrea Mortara (A)

Policlinico di Monza, Monza, Italy.

Toufic Khouri (T)

Policlinico di Monza, Monza, Italy.

Paolo Bruzzi (P)

Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy.

Paolo Ferrazzi (P)

Policlinico di Monza, Monza, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH